AT403122B - Therapeutische infusionszubereitung auf basis von aminosäurederivaten - Google Patents

Therapeutische infusionszubereitung auf basis von aminosäurederivaten Download PDF

Info

Publication number
AT403122B
AT403122B AT0260690A AT260690A AT403122B AT 403122 B AT403122 B AT 403122B AT 0260690 A AT0260690 A AT 0260690A AT 260690 A AT260690 A AT 260690A AT 403122 B AT403122 B AT 403122B
Authority
AT
Austria
Prior art keywords
acetylsalicylic acid
nmma
indomethacin
name
compound
Prior art date
Application number
AT0260690A
Other languages
German (de)
English (en)
Other versions
ATA260690A (de
Inventor
Pierre Braquet
De Lassauniere Pierre Chabrier
Jean-Michel Guillon
Michel Auguet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of ATA260690A publication Critical patent/ATA260690A/de
Application granted granted Critical
Publication of AT403122B publication Critical patent/AT403122B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0260690A 1989-12-22 1990-12-20 Therapeutische infusionszubereitung auf basis von aminosäurederivaten AT403122B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929076A GB8929076D0 (en) 1989-12-22 1989-12-22 Treatment of shock by blocking agents of edrf effect or formation

Publications (2)

Publication Number Publication Date
ATA260690A ATA260690A (de) 1997-04-15
AT403122B true AT403122B (de) 1997-11-25

Family

ID=10668428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260690A AT403122B (de) 1989-12-22 1990-12-20 Therapeutische infusionszubereitung auf basis von aminosäurederivaten

Country Status (21)

Country Link
US (1) US5081148A (instruction)
JP (1) JP2706578B2 (instruction)
KR (1) KR950005866B1 (instruction)
AT (1) AT403122B (instruction)
AU (1) AU629777B2 (instruction)
BE (1) BE1005531A5 (instruction)
CA (1) CA2032904C (instruction)
CH (1) CH681692A5 (instruction)
DE (1) DE4041283C2 (instruction)
DK (1) DK176168B1 (instruction)
FR (1) FR2656220B1 (instruction)
GB (2) GB8929076D0 (instruction)
HK (1) HK134693A (instruction)
IE (1) IE64403B1 (instruction)
IT (1) IT1246511B (instruction)
LU (1) LU87867A1 (instruction)
MY (1) MY105328A (instruction)
NL (1) NL194717C (instruction)
OA (1) OA09337A (instruction)
SE (1) SE504922C2 (instruction)
ZA (1) ZA9010004B (instruction)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
DK0724435T3 (da) * 1993-10-21 2002-11-25 Searle & Co Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
WO1995011231A1 (en) 1993-10-21 1995-04-27 G. D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
PT749418E (pt) * 1994-03-10 2001-01-31 Searle & Co Derivados de l-n6-(1-iminoetil)lisina uteis como inibidores de oxido nitrico sintetase
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
EP1609477B1 (en) * 1994-12-12 2011-11-09 Omeros Corporation Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
BR9608012A (pt) * 1995-04-20 1999-01-05 Searle & Co Agentes de amidino cíclicos úteis como inbidores da sintase do óxido nítrico
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US6620848B2 (en) 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
US6369272B1 (en) 1997-01-13 2002-04-09 Glaxosmithkline Nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
WO1999064426A1 (en) 1998-06-10 1999-12-16 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
AU2003290127A1 (en) 2003-12-30 2005-07-21 Vasopharm Biotech Gmbh 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
GB1195612A (en) * 1967-04-13 1970-06-17 Sumitomo Chemical Co An Injection
GB1525765A (en) * 1975-08-11 1978-09-20 Union Pharma Scient Appl Injectable solution
GB2066073A (en) * 1979-12-28 1981-07-08 Italfarmaco Spa Pharmaceutical compositions for the treatment of acute pulmonary edema some shock conditions and hyperfibrinolysis
WO1988006035A1 (en) * 1987-02-20 1988-08-25 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
JPS57197211A (en) * 1981-05-28 1982-12-03 Sumitomo Chem Co Ltd Useful eye drop composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPH0236570B2 (ja) * 1985-05-30 1990-08-17 Toko Yakuhin Kogyo Kk Shoenchintsunankozai
JPS6239524A (ja) * 1985-08-13 1987-02-20 Toko Yakuhin Kogyo Kk 消炎鎮痛軟膏剤
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
GB1195612A (en) * 1967-04-13 1970-06-17 Sumitomo Chemical Co An Injection
GB1525765A (en) * 1975-08-11 1978-09-20 Union Pharma Scient Appl Injectable solution
GB2066073A (en) * 1979-12-28 1981-07-08 Italfarmaco Spa Pharmaceutical compositions for the treatment of acute pulmonary edema some shock conditions and hyperfibrinolysis
WO1988006035A1 (en) * 1987-02-20 1988-08-25 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEM. ABSTR. VOL. 99 NO. 3, 18. JULI 1983 (COLUMBUS, OH, USA), SEITE 518, SPALTE 2-SEITE 519, SPALTE 1, ABSTRACT NO. 21279G, BARBUL A. ET AL. ''NITROGEN-SPARING AND IMMUNE MECHANISMS OF ARGININE: DIFFERENTIAL DOSE-DEPENDANT RESPONSES DURING POSTINJURY INTRAVENOUS HYPERALIMENTATION'', CURR. SURG. 1983, 40(2), 114-16 (ENG.). *

Also Published As

Publication number Publication date
SE9003974L (sv) 1991-06-23
GB9028013D0 (en) 1991-02-13
JP2706578B2 (ja) 1998-01-28
IT9022413A1 (it) 1991-06-23
NL9002720A (nl) 1991-07-16
MY105328A (en) 1994-09-30
SE9003974D0 (sv) 1990-12-12
NL194717B (nl) 2002-09-02
BE1005531A5 (fr) 1993-09-28
OA09337A (fr) 1992-09-15
IE904592A1 (en) 1991-07-03
FR2656220B1 (fr) 1995-01-13
NL194717C (nl) 2003-01-07
AU6837690A (en) 1991-06-27
DK304190A (da) 1991-06-23
IT9022413A0 (it) 1990-12-18
GB8929076D0 (en) 1990-02-28
HK134693A (en) 1993-12-17
JPH04364124A (ja) 1992-12-16
CA2032904C (en) 1996-01-02
IT1246511B (it) 1994-11-19
CH681692A5 (instruction) 1993-05-14
IE64403B1 (en) 1995-08-09
DK304190D0 (da) 1990-12-21
FR2656220A1 (fr) 1991-06-28
US5081148A (en) 1992-01-14
LU87867A1 (fr) 1991-05-07
ZA9010004B (en) 1991-10-30
CA2032904A1 (en) 1991-06-23
AU629777B2 (en) 1992-10-08
KR910011253A (ko) 1991-08-07
DE4041283C2 (de) 2000-07-13
KR950005866B1 (ko) 1995-06-02
SE504922C2 (sv) 1997-05-26
DE4041283A1 (de) 1991-06-27
GB2240041A (en) 1991-07-24
ATA260690A (de) 1997-04-15
DK176168B1 (da) 2006-11-13
GB2240041B (en) 1993-09-01

Similar Documents

Publication Publication Date Title
AT403122B (de) Therapeutische infusionszubereitung auf basis von aminosäurederivaten
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EP0065747B1 (de) Nonapeptid zur Behandlung von Suchtmittelentzugserscheinungen
DE69129115T2 (de) Neues verfahren zur behandlung von depression
EP0185210B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten
DE3119746C2 (instruction)
DE69232516T2 (de) Behandlung von neurologischen Zuständen durch eine Interleukin-i-inhibierende Verbindung
DE3033545A1 (de) Verwendung bekannter antiallergener mittel bei der bekaempfung von pathologischen mineralresorptionszustaenden
DE3852717T2 (de) Zusammensetzung für die Prophylaxe von Pneumocystis-carinii-Pneumonie.
CH636766A5 (de) Infusionsloesung zur behandlung von hepatischer encephalopathie und ein verfahren zu deren herstellung.
DE60203106T2 (de) Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen
EP0256385B1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel
AT408719B (de) Mittel zur behandlung von hepatitis c
EP0018550B1 (de) Mittel zur Behandlung von Muskelerkrankungen
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE69118685T3 (de) Zusammensetzungen für euthanasie
DE60306133T2 (de) Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE60012183T2 (de) Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen
DE3621036A1 (de) Fluessige ibuprofen-zubereitungen
DE3786682T2 (de) ACTH-Fragmente enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Schockzuständen sowie von respiratorischen und Herz-Kreislauf-Insuffizienzen.
DE3789173T2 (de) Verwendung von Ketamin zur Herstellung von Arzneimitteln zur Prävention oder Linderung der Effekte von Schlaganfall bei einer Person mit erhöhtem Risiko für Schlaganfall.
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE1670061C (de) 2 (2' Pyndyloxy)-athylguamdin und Verfahren zu dessen Herstellung
DE2336586A1 (de) 4-hydroxy-1,2,3-benztriazin als wirkstoff enthaltende arzneimittel und deren anwendung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee